Author:
Zhao Yinong,Shannon Kate,Buxton Jane A.,Ti Lianping,Genovy Theresa Anne,Braschel Melissa,Pick Neora,Kestler Mary,Deering Kathleen
Funder
National Institutes of Health
Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference96 articles.
1. Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS. 2013 Mar;27(6):973–9. 27(.
2. Wood E, Milloy MJ, Montaner JSG. HIV treatment as prevention among injection drug users. Curr Opin HIV AIDS. 2012 Mar;7(2):151–6.
3. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the Prevention of HIV-1 transmission. N Engl J Med. 2016 Sep;375(9):830–9.
4. Public Health Agency of Canada. Estimates of HIV incidence, prevalence and Canada’s progress on meeting the 90-90-90 HIV targets, 2018 [Internet]. Ottawa, Canada; 2020. Available from: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/summary-estimates-hiv-incidence-prevalence-canadasprogress-90-90-90.html
5. Gisslén M, Svedhem V, Lindborg L, Flamholc L, Norrgren H, Wendahl S, et al. Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets. HIV Med [Internet]. 2017 Apr 1 [cited 2021 May 11];18(4):305–7. Available from: http://www.sls.se/Global/RAV/